P21 Peptide
Also known as: P021 · CNTF(63-82)aa
A synthetic peptide derived from ciliary neurotrophic factor (CNTF) that increases BDNF production, enhances neuroplasticity, and improves cognitive function. Shows promise for Alzheimer's disease, depression, and age-related cognitive decline.
Mechanism of Action
P21 activates CNTF receptors and downstream JAK/STAT3 and MAPK signaling pathways that upregulate BDNF expression. Unlike Semax which increases BDNF acutely, P21 appears to sustainably increase BDNF production and promotes adult neurogenesis in the hippocampus.
Benefits
- Sustainably increases BDNF production
- Promotes adult neurogenesis in hippocampus
- Improves memory and learning
- Reduces cognitive deficits in Alzheimer's models
- Potential antidepressant effects
- Distinct mechanism from Semax/Selank
Side Effects & Risks
- Limited human data
- Injection site reactions
- Headache
Where to Buy P21 Peptide
1 option across 1 vendor · Sorted cheapest first · All include direct product link
From
$179.99
All links are affiliate links — PeptideWiki earns a commission at no extra cost to you. Coupon codes apply at checkout. Prices and availability may change. Always verify COA before purchasing.
Storage & Reconstitution Guide
Storage Temperature
-20°C (lyophilized)
24 months (lyophilized), 28 days (reconstituted)
Reconstitution Solvent
Bacteriostatic water (BAC water)
Swirl gently — do not shake or vortex
Handling Notes
Protect lyophilized peptide from moisture and light. Once reconstituted, keep refrigerated. Discard if solution becomes cloudy or discolored. Use insulin syringe for precise dosing.
Step-by-Step Reconstitution
Gather supplies
BAC water, insulin syringe, alcohol swabs, vial
Disinfect tops
Swab rubber stoppers of both vials with alcohol
Draw BAC water
Pull desired mL of BAC water into syringe
Inject slowly
Inject BAC water down the side of the peptide vial, swirl gently to dissolve
Research Protocol
- Dose Range
- 5–10 mg
- Frequency
- Once daily subcutaneous injection
- Cycle
- 4-8 weeks
- Routes
- subcutaneous injection
- Notes
- Research dose: 5-10mg/day subcutaneous. Limited human data — most research in rodent models.
Legal & Regulatory Status
Sold for research purposes only. Not for human use. Laws vary by country.
Commonly Stacked With
View all peptide stacks →External Resources
More in Cognitive & Nootropic
EDR tetrapeptide
A synthetic tripeptide (Glu-Asp-Arg) from the Khavinson peptide bioregulator series targeting the brain and pineal gland. Reduces neuronal apoptosis, improves cognitive function in aging models, and normalizes circadian rhythm disruption. Distinct from Epithalon despite also targeting the pineal gland.
Cerebral cortex peptide bioregulator
A peptide bioregulator targeting the cerebral cortex and CNS from the Khavinson series. Normalizes cortical neuron function, reduces age-related neurodegeneration, and improves cognitive function. Particularly studied for age-associated cognitive decline, vascular dementia, and post-stroke recovery.
GVS-111
A synthetic dipeptide nootropic approximately 1000x more potent than piracetam. Stimulates BDNF and NGF expression with significant neuroprotective and cognitive-enhancing effects.
FPF-1070
A complex mixture of low-molecular-weight neuropeptides derived from porcine brain proteins. The only peptide-based nootropic with robust clinical evidence for Alzheimer disease and brain injury.